Suppr超能文献

从有限的样本中进行幻灯片到幻灯片的组织转移和阵列组装,以进行全面的分子分析。

Slide-to-Slide Tissue Transfer and Array Assembly From Limited Samples for Comprehensive Molecular Profiling.

机构信息

Institute of Pathology, Alb Fils Clinics GmbH, Göppingen, Germany; Institute of Pathology, University Hospital Ulm, Ulm, Germany.

Center for Integrated Diagnostics, Department of Pathology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts.

出版信息

Lab Invest. 2023 May;103(5):100062. doi: 10.1016/j.labinv.2023.100062. Epub 2023 Jan 18.

Abstract

Tissue microarrays (TMA) have become an important tool in high-throughput molecular profiling of tissue samples in the translational research setting. Unfortunately, high-throughput profiling in small biopsy specimens or rare tumor samples (eg, orphan diseases or unusual tumors) is often precluded owing to limited amounts of tissue. To overcome these challenges, we devised a method that allows tissue transfer and construction of TMAs from individual 2- to 5-μm sections for subsequent molecular profiling. We named the technique slide-to-slide (STS) transfer, and it requires a series of chemical exposures (so-called xylene-methacrylate exchange) in combination with rehydrated lifting, microdissection of donor tissues into multiple small tissue fragments (methacrylate-tissue tiles), and subsequent remounting on separate recipient slides (STS array slide). We developed the STS technique by assessing the efficacy and analytical performance using the following key metrics: (a) dropout rate, (b) transfer efficacy, (c) success rates using different antigen-retrieval methods, (d) success rates of immunohistochemical stains, (e) fluorescent in situ hybridization success rates, and (f) DNA and (g) RNA extraction yields from single slides, which all functioned appropriately. The dropout rate ranged from 0.7% to 6.2%; however, we applied the same STS technique successfully to fill these dropouts ("rescue" transfer). Hematoxylin and eosin assessment of donor slides confirmed a transfer efficacy of >93%, depending on the size of the tissue (range, 76%-100%). Fluorescent in situ hybridization success rates and nucleic acid yields were comparable with those of traditional workflows. In this study, we present a quick, reliable, and cost-effective method that offers the key advantages of TMAs and other molecular techniques-even when tissue is sparse. The perspectives of this technology in biomedical sciences and clinical practice are promising, given that it allows laboratories to create more data with less tissue.

摘要

组织微阵列(TMA)已成为转化研究中高通量分子分析组织样本的重要工具。然而,由于组织量有限,通常无法对小活检标本或罕见肿瘤样本(例如孤儿病或不常见的肿瘤)进行高通量分析。为了克服这些挑战,我们设计了一种方法,可以在单个 2-5μm 切片上进行组织转移和 TMA 构建,以进行后续的分子分析。我们将该技术命名为玻片到玻片(STS)转移,它需要一系列化学暴露(所谓的二甲苯-甲基丙烯酸酯交换),结合再水化提升、将供体组织切成多个小块(甲基丙烯酸酯-组织小块),以及随后在单独的接收载玻片上重新安装(STS 阵列载玻片)。我们通过评估以下关键指标的有效性和分析性能来开发 STS 技术:(a)缺失率、(b)转移效率、(c)使用不同抗原回收方法的成功率、(d)免疫组织化学染色的成功率、(e)荧光原位杂交的成功率,以及(f)从单个载玻片提取的 DNA 和(g)RNA 的产量,所有这些功能都正常。缺失率范围为 0.7%至 6.2%;然而,我们应用相同的 STS 技术成功地填补了这些缺失(“救援”转移)。根据组织大小,供体载玻片的苏木精和伊红评估确认转移效率>93%(范围为 76%-100%)。荧光原位杂交成功率和核酸产量与传统工作流程相当。在这项研究中,我们提出了一种快速、可靠且具有成本效益的方法,即使在组织稀疏的情况下,也提供了 TMA 和其他分子技术的关键优势。鉴于该技术允许实验室用更少的组织生成更多的数据,因此它在生物医学科学和临床实践中的前景是有希望的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fa8/10198954/a86055ed9c82/nihms-1874815-f0001.jpg

相似文献

2
Tissue microarrays: an overview.组织微阵列:概述
Methods Mol Biol. 2008;441:91-103. doi: 10.1007/978-1-60327-047-2_6.
5
Tissue microarrays: construction and uses.组织微阵列:构建与应用
Methods Mol Biol. 2011;724:23-35. doi: 10.1007/978-1-61779-055-3_2.
6
Tissue Microarrays.组织微阵列
Methods Mol Biol. 2016;1381:53-65. doi: 10.1007/978-1-4939-3204-7_3.
9
Tissue microarrays: construction and use.组织微阵列:构建与应用。
Methods Mol Biol. 2013;980:13-28. doi: 10.1007/978-1-62703-287-2_2.
10
Protocols for Tissue Microarrays in Prostate Cancer Studies.前列腺癌研究中组织微阵列的方案
Methods Mol Biol. 2018;1786:103-116. doi: 10.1007/978-1-4939-7845-8_6.

本文引用的文献

3
Museum of spatial transcriptomics.空间转录组学博物馆。
Nat Methods. 2022 May;19(5):534-546. doi: 10.1038/s41592-022-01409-2. Epub 2022 Mar 10.
8
Review of precision cancer medicine: Evolution of the treatment paradigm.精准肿瘤医学述评:治疗范式的演变。
Cancer Treat Rev. 2020 Jun;86:102019. doi: 10.1016/j.ctrv.2020.102019. Epub 2020 Mar 31.
9
Allocation of scarce biospecimens for use in research.分配稀缺生物样本用于研究。
J Med Ethics. 2021 Nov;47(11):740-743. doi: 10.1136/medethics-2019-105766. Epub 2020 Mar 27.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验